#

## Comprehensive Workflow for Level 1 Trauma Center Teaching

### Evidence-Based, Data-Driven, Medical Excellence Standard

  

**Version:** 2.0 - Production Template

**Date Created:** November 13, 2025

**Institution:** University of Virginia Health System (Adaptable)

**Audience:** PGY 3-5 Residents, Fellows, Critical Care Teams

  
```table-of-contents
title: 
style: nestedList # TOC style (nestedList|nestedOrderedList|inlineFirstLevel)
minLevel: 0 # Include headings from the specified level
maxLevel: 0 # Include headings up to the specified level
include: 
exclude: 
includeLinks: true # Make headings clickable
hideWhenEmpty: false # Hide TOC if no headings are found
debugInConsole: false # Print debug info in Obsidian console
```
---

  

# EXECUTIVE SUMMARY

  

This template provides a **COMPLETE, REUSABLE SYSTEM** for analyzing any medical journal article and transforming it into:

- ✅ Comprehensive journal club presentation

- ✅ Clinical teaching materials (chalk talk)

- ✅ Implementation guides for institutional use

- ✅ Gamma-ready slide presentations

  

**Time to Complete:** 60-90 minutes per article (using this template + AI assistance)

  

---

  

## PART I: COMPREHENSIVE JOURNAL CLUB ANALYSIS

  

### SECTION 1: PRESENTER INFORMATION

  

- ☐ **Presenter Name:** [Name], MD

- ☐ **Presenter Title:** [Title/Specialty]

- ☐ **Presentation Date:** [Date to be scheduled]

- ☐ **Institution:** [Your Institution Name]

- ☐ **Department:** [Department Name]

- ☐ **Journal Club Title:** [Title - typically same as article]

  

**PRIMARY ARTICLE CITATION:**

- ☐ **Authors:** [Last Name First Author et al.]

- ☐ **Title:** [Full Article Title]

- ☐ **Journal:** [Journal Name]

- ☐ **Year:** [YYYY]

- ☐ **Volume(Issue):Pages:** [Vol(#):###-###]

- ☐ **PMID:** [PubMed ID if available]

- ☐ **DOI:** [Digital Object Identifier]

- ☐ **URL:** [Direct link to article]

  

**Article Details:**

- ☐ **Publication Type:** [Original Research | Review | Meta-Analysis | Systematic Review | Case Series | RCT | Observational]

- ☐ **Study Design:** [Describe: prospective/retrospective, cohort, case-control, etc.]

- ☐ **Level of Evidence:** [Grade using GRADE or Oxford CEBM]

- ☐ **Study Period:** [Time period of data collection]

- ☐ **Follow-up Duration:** [If applicable]

  

---

  

### SECTION 2: STUDY BACKGROUND & CLINICAL PROBLEM

  

**2A. Clinical Context**

  

- ☐ **What is the clinical problem being addressed?**

- [2-3 sentence summary of the clinical question]

- Prevalence/incidence data in trauma/critical care setting

- Why this matters to Level 1 trauma centers

  

- ☐ **Current standard of care (prior to this study):**

- [Describe what clinicians were doing before this evidence]

- Gaps in knowledge or practice variation

- Controversies or unresolved questions

  

- ☐ **Historical context:**

- [Brief timeline: When was this entity first described?]

- Key milestones in understanding

- Evolution of terminology (if applicable)

  

**2B. Population Affected**

  

- ☐ **Who gets this condition/complication?**

- Patient demographics (age, sex, injury patterns)

- Risk factors

- Prevalence/incidence in different populations (TBI, polytrauma, specific injury types)

  

- ☐ **Why does it matter clinically?**

- Impact on morbidity/mortality

- Effect on length of stay, complications, functional outcomes

- Economic/resource utilization implications

  

**2C. Prior Evidence Base**

  

- ☐ **What was known before this study?**

- [List 3-5 key prior studies with brief findings]

- Consensus statements or guidelines (if available)

- Areas of uncertainty or controversy

  

---

  

### SECTION 3: STUDY DESIGN & METHODOLOGY

  

**3A. Study Objectives**

  

- ☐ **Primary research question:** [State in PICO format if applicable]

- Population:

- Intervention/Exposure:

- Comparison:

- Outcome:

  

- ☐ **Secondary research questions:** [List if multiple aims]

  

**3B. Study Design Details**

  

- ☐ **Study type:** [Prospective cohort | RCT | Systematic review | Meta-analysis | Other]

- ☐ **Setting:** [Single center | Multi-center; Country/region]

- ☐ **Study period:** [Dates of enrollment or data collection]

- ☐ **Sample size:**

- Total N = [#]

- Study group(s) N = [#]

- Control/comparison group N = [#] (if applicable)

- ☐ **Inclusion criteria:** [List key criteria]

- ☐ **Exclusion criteria:** [List key criteria]

  

**3C. Data Collection & Outcomes**

  

- ☐ **Primary outcome measure:** [Clearly define]

- ☐ **Secondary outcome measures:** [List all]

- ☐ **How were outcomes measured?**

- Validated scales/tools used

- Timing of assessments

- Who performed assessments (blinded?)

  

- ☐ **Data sources:**

- Prospectively collected vs. retrospective chart review

- Registry data? (if yes, which registry)

- Electronic health records

- Direct patient assessment

  

**3D. Statistical Methods**

  

- ☐ **Statistical tests used:** [List primary analyses]

- ☐ **Power calculation:** [Was study adequately powered?]

- ☐ **Handling of missing data:** [How addressed?]

- ☐ **Confounders addressed:** [List variables adjusted for]

- ☐ **Subgroup analyses:** [Planned? Post-hoc?]

  

---

  

### SECTION 4: KEY RESULTS - QUANTITATIVE SYNTHESIS

  

**4A. Study Population Characteristics**

  

- ☐ **Baseline demographics:**

- Mean age: [##] years

- Sex distribution: [##%] male

- Injury severity: [ISS, GCS, or other relevant score]

- Other relevant baseline characteristics

  

- ☐ **Comparison of groups (if applicable):**

- Were groups balanced at baseline?

- Any significant differences requiring adjustment?

  

**4B. Primary Outcome Results**

  

- ☐ **Primary outcome finding:**

- [State result with specific numbers]

- Effect size (OR, RR, HR, mean difference, etc.)

- 95% Confidence Interval

- p-value

- Clinical significance vs. statistical significance

  

**Example format:**

```

Primary outcome: [Outcome name]

- Intervention group: [##]% (n=[#]/[#])

- Control group: [##]% (n=[#]/[#])

- Effect: OR [#.##] (95% CI [#.##-#.##]), p=[#.###]

```

  

**4C. Secondary Outcome Results**

  

- ☐ **Secondary outcome 1:** [Name]

- [Results in same format as above]

- ☐ **Secondary outcome 2:** [Name]

- [Results in same format as above]

  

- ☐ **Additional findings:**

- Subgroup analyses (if performed)

- Adverse events or complications

- Unexpected findings

  

**4D. Create Results Tables**

  

**Table 1: Baseline Characteristics**

| Variable | Group 1 (n=[#]) | Group 2 (n=[#]) | p-value |

|---|---|---|---|

| Age (mean ± SD) | [##±##] | [##±##] | [#.###] |

| Sex (% male) | [##%] | [##%] | [#.###] |

| [Add relevant variables] | | | |

  

**Table 2: Primary and Secondary Outcomes**

| Outcome | Group 1 | Group 2 | Effect Size (95% CI) | p-value |

|---|---|---|---|---|

| Primary outcome | [##%] | [##%] | [#.## (#.##-#.##)] | [#.###] |

| Secondary outcome 1 | [##%] | [##%] | [#.## (#.##-#.##)] | [#.###] |

  

---

  

### SECTION 5: CRITICAL APPRAISAL

  

**5A. Strengths of the Study**

  

- ☐ **Methodological strengths:**

- [List 3-5 specific strengths]

- Examples: Large sample size, prospective design, validated outcome measures, long follow-up, multi-center, etc.

  

- ☐ **Clinical relevance:**

- [How do findings apply to your practice?]

- Generalizability to Level 1 trauma center population

  

**5B. Limitations of the Study**

  

- ☐ **Internal validity concerns:**

- [Selection bias? Information bias? Confounding?]

- Missing data issues

- Dropout/loss to follow-up rates

  

- ☐ **External validity concerns:**

- [Generalizability limitations]

- Population differences from your institution

- Temporal changes (if older study)

  

- ☐ **Statistical limitations:**

- [Underpowered? Multiple comparisons without correction?]

- Subgroup analyses without pre-specification

  

- ☐ **Other limitations:**

- Funding source/conflicts of interest

- Industry sponsorship concerns

- Author-reported limitations

  

**5C. GRADE Assessment (for interventions/treatments)**

  

Using GRADE criteria, rate the quality of evidence:

  

| Domain | Rating | Justification |

|---|---|---|

| **Risk of Bias** | High / Moderate / Low | [Explain] |

| **Inconsistency** | High / Moderate / Low | [Explain] |

| **Indirectness** | High / Moderate / Low | [Explain] |

| **Imprecision** | High / Moderate / Low | [Explain] |

| **Publication Bias** | High / Moderate / Low | [Explain] |

  

**OVERALL GRADE:** [High | Moderate | Low | Very Low]

  

---

  

### SECTION 6: BIOLOGICAL PLAUSIBILITY & MECHANISM

  

**6A. Mechanism of Action (if applicable)**

  

- ☐ **What is the proposed biological mechanism?**

- [Explain pathophysiology in 2-3 paragraphs]

- Key physiologic pathways involved

- Molecular/cellular mechanisms (if known)

  

- ☐ **Supporting biomarker or laboratory evidence:**

- [List relevant biomarkers, lab findings, or imaging]

- Quantitative changes observed (e.g., "Catecholamines ↑ 200-300%")

  

**6B. Prior Mechanistic Studies**

  

- ☐ **Animal or basic science evidence:**

- [Cite key studies]

- ☐ **Human mechanistic studies:**

- [Cite key studies]

  

**6C. Does the Mechanism Make Sense?**

  

- ☐ **Coherence with established biology:** [Yes/No - explain]

- ☐ **Consistency with prior observations:** [Yes/No - explain]

  

---

  

### SECTION 7: CLINICAL RELEVANCE & APPLICATION

  

**7A. How Does This Change Practice?**

  

- ☐ **Immediate practice changes:**

- [List specific actionable changes]

- What will you START doing?

- What will you STOP doing?

- What will you CONTINUE but modify?

  

- ☐ **Diagnostic implications:**

- New diagnostic criteria or tools

- Screening protocols to implement

  

- ☐ **Treatment implications:**

- New therapeutic approaches

- Medication dosing changes

- Surgical technique modifications

- Supportive care changes

  

**7B. Implementation Barriers**

  

- ☐ **What barriers exist to implementation at your institution?**

- Resource constraints (staffing, equipment, cost)

- Training needs

- Workflow integration challenges

- Cultural/practice pattern resistance

  

**7C. Institutional Adaptation Plan**

  

- ☐ **How can you implement these findings at your institution?**

- Week 1 actions: [List specific tasks]

- Month 1 actions: [List specific tasks]

- Ongoing monitoring: [What metrics will you track?]

  

---

  

### SECTION 8: FUTURE RESEARCH DIRECTIONS

  

**8A. Unanswered Questions**

  

- ☐ **What questions does this study raise?**

- [List 3-5 specific research questions]

  

**8B. Suggested Future Studies**

  

For each unanswered question, propose a study design:

  

- ☐ **Research Question 1:** [State question]

- Proposed study design: [RCT | Cohort | Registry study | Other]

- Population: [Define]

- Intervention/Exposure: [Define]

- Outcome measures: [Primary and secondary]

- Timeline: [Estimated duration]

  

- ☐ **Research Question 2:** [Repeat format above]

  

**8C. Ongoing Trials**

  

- ☐ **Are there ongoing trials addressing these questions?**

- [List ClinicalTrials.gov registrations if known]

- Expected completion dates

  

---

  

### SECTION 9: DISCUSSION QUESTIONS FOR JOURNAL CLUB

  

**Tier 1: Knowledge Questions (Recall)**

1. What was the primary outcome of this study?

2. What was the study design?

3. What were the inclusion/exclusion criteria?

  

**Tier 2: Comprehension Questions (Understanding)**

4. Why did the authors choose this study design?

5. How do the results compare to prior studies on this topic?

6. What are the key limitations of this study?

  

**Tier 3: Application Questions (Using Knowledge)**

7. How would you apply these findings to a patient you saw recently?

8. What changes would you make to your practice based on this study?

9. How would you counsel a patient about this intervention?

  

**Tier 4: Analysis Questions (Breaking Down)**

10. What biases might have affected the results?

11. Are the conclusions justified by the data presented?

12. What alternative explanations exist for the findings?

  

**Tier 5: Synthesis Questions (Integrating)**

13. How does this study fit into the broader literature on this topic?

14. What would be the next logical study to conduct?

15. If you were to design a follow-up study, what would you do differently?

  

---

  

## PART II: COMPREHENSIVE CHALK TALK (ADDIE-I9 FRAMEWORK)

  

### ADDIE MODEL - Instructional Design Framework

  

**Phase 1: ANALYZE**

  

**1A. Learner Profile**

  

- ☐ **Target audience:** [PGY level, specialty, experience]

- ☐ **Prior knowledge expected:**

- [What should learners already know?]

- [Prerequisite concepts or skills]

  

- ☐ **Learning gaps:**

- [What do learners currently NOT know that they need to?]

- [Common misconceptions to address]

  

**1B. Needs Assessment**

  

- ☐ **Why is this topic important for learners?**

- Clinical relevance

- Frequency encountered in practice

- Impact on patient outcomes

  

- ☐ **How does this align with residency curriculum?**

- ACGME competencies addressed

- Milestone level targeted

  

**1C. Scope Definition**

  

- ☐ **Time available:** [15 min | 30 min | 45 min | 60 min]

- ☐ **Setting:** [Didactic lecture | Bedside teaching | Simulation | Grand rounds]

- ☐ **Resources available:** [Whiteboard | Slides | Handouts | Simulation equipment]

  

---

  

**Phase 2: DESIGN**

  

**2A. Learning Objectives (SMART Format)**

  

Write 3-5 learning objectives using Bloom's taxonomy:

  

- ☐ **Objective 1:** [Use action verb: define, identify, describe, explain, analyze, synthesize, evaluate]

- Example: "By the end of this session, learners will be able to **calculate** the PSH-AM score in <2 minutes using a patient scenario."

  

- ☐ **Objective 2:** [Action verb + specific outcome + measurable criteria]

  

- ☐ **Objective 3:** [Action verb + specific outcome + measurable criteria]

  

- ☐ **Objective 4:** [Action verb + specific outcome + measurable criteria]

  

- ☐ **Objective 5:** [Action verb + specific outcome + measurable criteria]

  

**2B. Assessment Strategy**

  

- ☐ **How will you assess learning?**

- Pre-test/Post-test

- Case-based questions during session

- Direct observation of skill performance

- Follow-up clinical application

  

**2C. Chalk Talk Board Map (Visual Outline)**

  

- ☐ **Panel 1 (Left Board):** [Topic overview + key definitions]

- [Sketch layout: Where will title go? Definitions? Key concept boxes?]

  

- ☐ **Panel 2 (Right Board):** [Management algorithm OR pathophysiology diagram]

- [Sketch layout: Flowchart? Diagram? Table?]

  

**Design Rationale:**

- Why this layout? [Explain visual hierarchy and flow]

- Pre-drawn vs. co-created? [Which elements will you draw beforehand vs. build with learners?]

  

---

  

**Phase 3: DEVELOP**

  

**3A. Content Development - 8 Core Teaching Points**

  

For a 45-minute chalk talk, develop ~8 talking points (5-6 minutes each):

  

**Talking Point 1:** [Title - e.g., "What is PSH?"]

- **Key message:** [1 sentence takeaway]

- **Content details:** [2-3 paragraphs of what you'll say]

- **Visual on board:** [What will you draw/write?]

- **Interaction:** [Question to ask learners or active learning moment]

- **Time:** ~5 minutes

  

**Talking Point 2:** [Title - e.g., "Why does PSH happen?"]

- **Key message:**

- **Content details:**

- **Visual on board:**

- **Interaction:**

- **Time:** ~5 minutes

  

[Repeat for all 8 talking points]

  

**3B. Mnemonic or Memory Aid**

  

- ☐ **Create a mnemonic:** [E.g., "THE STORM" for PSH features]

- [Each letter = key concept]

- [Easy to remember, clinically relevant]

  

**3C. Common Pitfalls to Highlight**

  

- ☐ **Pitfall 1:** [Common mistake clinicians make]

- Why it's wrong:

- Correct approach:

  

- ☐ **Pitfall 2:** [Repeat format]

  

- ☐ **Pitfall 3:** [Repeat format]

  

**3D. Clinical Pearls (Top 5)**

  

- ☐ **Pearl 1:** [Actionable clinical tip for tomorrow]

- ☐ **Pearl 2:** [Actionable clinical tip]

- ☐ **Pearl 3:** [Actionable clinical tip]

- ☐ **Pearl 4:** [Actionable clinical tip]

- ☐ **Pearl 5:** [Actionable clinical tip]

  

**3E. Interactive Case Scenario**

  

**Case Setup:**

- Patient: [Age, sex, injury/presentation]

- Setting: [ICU day #, POD #, etc.]

- Vital signs: [Specific numbers]

- Physical exam: [Key findings]

  

**Questions to Ask Learners (Progressive Disclosure):**

1. "What's your differential diagnosis?"

2. "What test or score would you use?"

3. "Walk me through your management plan."

4. "When would you escalate therapy?"

  

**Expected Answers:**

- [What you hope learners will say]

- [How to guide if they struggle]

- [Teachable moments to highlight]

  

**3F. References for Handout**

  

- ☐ **Primary article:** [Full citation with PMID/DOI]

- ☐ **Key supporting references:** [List 5-10 essential papers]

- ☐ **Guidelines or consensus statements:** [If available]

- ☐ **Online resources:** [Links to calculators, videos, protocols]

  

---

  

**Phase 4: IMPLEMENT**

  

**4A. Gagné's Nine Events of Instruction**

  

**Event 1: Gain Attention (0-3 minutes)**

- ☐ **Hook:** [Clinical scenario, provocative question, surprising statistic]

- Example: "You're called at 2 AM to a patient with..."

- Why this works: [Relevance, urgency, intrigue]

  

**Event 2: Inform Objectives (3-5 minutes)**

- ☐ **State learning objectives explicitly:**

- "By the end, you'll be able to..."

- [List 3-5 objectives from Design phase]

  

**Event 3: Stimulate Recall of Prior Knowledge (5-8 minutes)**

- ☐ **Connect to what learners already know:**

- "What do you know about [related topic]?"

- "When have you seen this clinically?"

- [Build from familiar to novel]

  

**Event 4: Present Content (8-30 minutes)**

- ☐ **Deliver core teaching points:**

- [Use the 8 talking points from Develop phase]

- Draw on board progressively

- Use think-aloud technique ("I'm drawing this because...")

  

**Event 5: Provide Guidance (30-35 minutes)**

- ☐ **Scaffold learning:**

- Worked examples

- Step-by-step demonstration (e.g., calculating a score)

- Anticipate confusion points and address proactively

  

**Event 6: Elicit Performance (35-40 minutes)**

- ☐ **Learners practice:**

- Interactive case: "Now YOU calculate the score"

- Polling questions

- Think-pair-share

  

**Event 7: Provide Feedback (40-43 minutes)**

- ☐ **Give specific, immediate feedback:**

- "Great! You correctly identified..."

- "Not quite - remember that..."

- Reinforce correct answers; gently correct errors

  

**Event 8: Assess Performance (43-45 minutes)**

- ☐ **Check for understanding:**

- Quick verbal quiz

- Show of hands: "Who feels confident using this approach?"

- Clarify any remaining confusion

  

**Event 9: Enhance Retention and Transfer (45-50 minutes)**

- ☐ **Summarize and solidify:**

- "The top 3 things to remember are..."

- Provide handout with key points + references

- Preview next steps: "Tomorrow when you see a patient..."

  

**4B. Contingency Plans**

  

- ☐ **If running short on time (30 minutes instead of 45):**

- [Which talking points can you condense or skip?]

- [What's the absolute minimum to cover?]

  

- ☐ **If running long (need to extend to 60 minutes):**

- [What additional depth can you add?]

- [Extra cases or discussion questions?]

  

- ☐ **If learners seem confused:**

- [Pause and check: "Does this make sense?"]

- [Have backup analogies or alternative explanations ready]

  

---

  

**Phase 5: EVALUATE**

  

**5A. Immediate Evaluation (During/End of Session)**

  

- ☐ **Observe learner engagement:**

- Eye contact, note-taking, questions asked

- Participation in case discussions

- Confidence in answers

  

- ☐ **Quick feedback survey (1-2 minutes):**

- "On a scale of 1-5, how useful was this session?"

- "What was the most valuable thing you learned?"

- "What could be improved?"

  

**5B. Short-Term Evaluation (1-2 weeks post-session)**

  

- ☐ **Clinical application check:**

- "Have you used this approach with a patient?"

- "What worked well? What was challenging?"

- [Collect anecdotes/case examples]

  

- ☐ **Knowledge retention:**

- Quick email quiz (5 questions)

- Review during next teaching session

  

**5C. Long-Term Evaluation (3 months post-session)**

  

- ☐ **Practice change metrics:**

- % of eligible patients screened (if screening tool introduced)

- Medication usage patterns (if pharmacotherapy discussed)

- Consultation patterns (if referral pathway discussed)

  

- ☐ **Learner confidence:**

- Survey: "How confident are you now managing [condition]?"

- Compare to pre-teaching confidence level

  

**5D. Iterate and Improve**

  

- ☐ **What worked well?** [Keep for next time]

- ☐ **What didn't work?** [Modify or remove]

- ☐ **What was missing?** [Add for next iteration]

- ☐ **Time management?** [Adjust pacing]

  

---

  

## PART III: GAMMA PRESENTATION GENERATION

  

### Step-by-Step Gamma Slide Creation

  

**Option 1: SHORT VERSION (15-20 minutes, 16 slides)**

  

Use this structure:

1. Title + Citation

2. Opening case

3. Definition

4. Epidemiology (brief)

5. Diagnostic tool/criteria

6. Differential diagnosis

7. Pathophysiology (1 slide)

8. Outcomes (brief)

9. Management Tier 1

10. Management Tier 2

11. Management Tier 3

12. Pitfalls (what NOT to do)

13. Key pearls (5 takeaways)

14. Case scenario

15. References

16. Takeaway message

  

**Option 2: MEDIUM VERSION (30-35 minutes, 22-24 slides)**

  

Add to Short version:

- Historical context

- Detailed epidemiology table

- Biomarker evidence

- Neuroimaging findings

- Detailed outcomes table

- Trigger prevention

- Supportive therapy

- Decision tree/algorithm

- Implementation checklist

- Common Q&A

  

**Option 3: LONG VERSION (45-60 minutes, 30 slides)**

  

Add to Medium version:

- Detailed pathophysiology diagrams

- Multiple outcome tables

- Medication quick reference cards

- Institutional adaptation plans

- Multiple case scenarios

- Comprehensive references with URLs

  

---

  

### Gamma Markdown Formatting Guidelines

  

**Slide Structure:**

```

# Slide Title

  

Bullet point 1 | Bullet point 2 | Bullet point 3 | Key finding with data | Clinical pearl

  

---

  

Next slide starts after three dashes

```

  

**Best Practices:**

- Use pipe `|` to separate related points on same line

- Keep slides concise (max 6-8 lines per slide)

- Use ✓ ✗ ☐ ❌ ↑ ↓ symbols for visual interest

- Include specific numbers, percentages, effect sizes

- End with "---" to create slide break

  

---

  

## PART IV: INSTITUTIONAL IMPLEMENTATION GUIDE

  

### Week 1: Foundation

  

- ☐ **Action 1:** Share article with team (email PDF + 1-page summary)

- ☐ **Action 2:** Schedule journal club presentation date

- ☐ **Action 3:** Create pocket cards or quick reference guides (if applicable)

- ☐ **Action 4:** Alert key stakeholders (ICU director, pharmacy, nursing)

  

### Week 2: Education & Training

  

- ☐ **Action 1:** Deliver journal club presentation

- ☐ **Action 2:** Deliver chalk talk to residents

- ☐ **Action 3:** Create EHR order sets or documentation templates

- ☐ **Action 4:** Train nursing staff (if workflow changes)

  

### Month 1: Integration

  

- ☐ **Action 1:** Track baseline metrics (define what to measure)

- ☐ **Action 2:** Establish weekly case conference (if appropriate)

- ☐ **Action 3:** Embed new protocol into routine care

- ☐ **Action 4:** Create outcome dashboard

  

### Month 3: Evaluation

  

- ☐ **Action 1:** Analyze outcomes (compare to baseline or historical controls)

- ☐ **Action 2:** Gather feedback (residents, nursing, attendings)

- ☐ **Action 3:** Celebrate wins (share success stories)

- ☐ **Action 4:** Iterate protocol based on real-world experience

  

### Ongoing: Sustain

  

- ☐ **Action 1:** Monthly or quarterly metrics review

- ☐ **Action 2:** Annual resident education (make it standard curriculum)

- ☐ **Action 3:** Update protocol as new evidence emerges

- ☐ **Action 4:** Publish QI project or outcomes (consider manuscript)

  

---

  

## PART V: QUALITY CHECKLIST

  

Before finalizing your analysis, ensure:

  

**Content Completeness:**

- ☐ All sections of journal club template filled

- ☐ All checkboxes completed

- ☐ Tables created with actual data (no placeholders)

- ☐ References cited with PMID/DOI

- ☐ Clinical pearls actionable and specific

  

**Teaching Materials:**

- ☐ Learning objectives written in SMART format

- ☐ 8 talking points developed with timing

- ☐ Interactive case created with questions + answers

- ☐ Mnemonic or memory aid included

- ☐ Pitfalls and pearls identified

  

**Gamma Presentation:**

- ☐ All slides use proper markdown formatting

- ☐ Pipe `|` separators used correctly

- ☐ Slide breaks `---` after each slide

- ☐ Specific data included (no vague statements)

- ☐ References with URLs at end

  

**Implementation:**

- ☐ Week 1-Month 3 action items defined

- ☐ Metrics to track identified

- ☐ Stakeholders identified

- ☐ Barriers anticipated

  

**Excellence Standard:**

- ☐ High-level analysis appropriate for trauma critical care audience

- ☐ Data-driven (specific numbers, effect sizes, confidence intervals)

- ☐ Evidence-based (properly cited sources)

- ☐ Actionable (clear next steps for clinicians)

  

---

  

## PART VI: REUSABLE PROMPT FOR AI ASSISTANCE

  

**Copy-Paste Prompt Template:**

  

```

I have a medical journal article [ATTACH PDF or provide PMID/DOI].

  

Please perform a COMPREHENSIVE ANALYSIS using the Universal Journal Club & Chalk Talk Template for a Level 1 Trauma Center.

  

Complete ALL sections:

- Part I: Comprehensive Journal Club Analysis (9 sections)

- Part II: Chalk Talk using ADDIE-I9 Framework

- Part III: Generate 3 Gamma-ready presentations (Short 16 slides, Medium 22 slides, Long 30 slides)

- Part IV: Institutional Implementation Guide

  

Requirements:

✓ Fill every checkbox with specific data (no placeholders)

✓ Include exact numbers, percentages, effect sizes, p-values

✓ Create tables with actual study data

✓ Cite all sources with PMID/DOI

✓ Make clinical pearls actionable

✓ Ensure Gamma slides use proper markdown formatting (pipe separators | and slide breaks ---)

✓ High-level analysis for trauma/critical care physicians

✓ Data-driven, evidence-based, excellence standard

  

Topic: [INSERT ARTICLE TITLE OR CLINICAL TOPIC]

```

  

---

  

## APPENDIX: EXAMPLE COMPLETED SECTIONS

  

[For reference, see the PSH analysis completed earlier in this conversation as the gold standard example]

  

---

  

**END OF UNIVERSAL TEMPLATE**

  

**Version:** 2.0

**Last Updated:** November 13, 2025

**Next Review:** Quarterly or as needed for template improvements